# Vaxcyte, Inc.: Form 8-K, filed Oct 16, 2023

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2023-10-16
- Accepted by EDGAR: Oct 16, 2023, 08:01 ET
- Period: 2023-10-13
- Accession: 0001193125-23-256533
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000119312523256533/d572225d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000119312523256533/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000119312523256533/d572225d8k.htm

Filed Oct 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-256533. Last ingested by Listed: Nov 6, 2026, 13:09 ET. No prices; not investment advice.